Real-World study reveals how two liver cancer drugs stack up in patients with cirrhosis

This study looked at how well two different treatments work in real life for people with advanced liver cancer and cirrhosis. Researchers compared a combination of two drugs (Atezolizumab and Bevacizumab) to a group of similar patients who took a different type of drug (tyrosine kinase inhibitors). The goal was to see which treatment was safer and more effective, especially in patients with mild liver problems. The study included 38 patients and has already been completed.